Hims & Hers shares tumble after company misses on margin, says may stop selling some weight loss drugs

The New York Stock Exchange with a Hims & Hers Health banner is pictured in the Manhattan borough of New York City. Hims & Hers Health shares plunged 18% in extended trading on Monday after investors looked past better-than-expected revenue and earnings and focused instead on the disappointing gross margin. Here's how the company did, compared to analysts' consensus estimates from LSEG: Earnings per share: 11 cents vs. 10 cents expected 11 cents vs. 10 cents expected Revenue: $481 million vs. $470 million expected Revenue at the telehealth company increased 95% in the fourth quarter from $246.6 million during the same period last year, according to a release. However, the company's gross margin, or the profit left after accounting for the cost of goods sold, was 77%, while analysts polled by StreetAccount were expecting 78.4%. It is the second big stock drop for Hims & Hers in a matter of days. The shares tumbled 26% on Friday after the U.S. Food and Drug Administration announce ... Read full article.